Ani Pharmaceuticals (ANIP) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Ani Pharmaceuticals (ANIP) over the last 16 years, with Q3 2025 value amounting to $1.13.
- Ani Pharmaceuticals' EPS (Weighted Average and Diluted) rose 18897.64% to $1.13 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.63, marking a year-over-year increase of 38596.49%. This contributed to the annual value of -$1.04 for FY2024, which is 21061.42% down from last year.
- According to the latest figures from Q3 2025, Ani Pharmaceuticals' EPS (Weighted Average and Diluted) is $1.13, which was up 18897.64% from $0.36 recorded in Q2 2025.
- Over the past 5 years, Ani Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at $1.13 during Q3 2025, and registered a low of -$1.93 during Q4 2021.
- For the 5-year period, Ani Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.24, with its median value being -$0.14 (2024).
- Per our database at Business Quant, Ani Pharmaceuticals' EPS (Weighted Average and Diluted) tumbled by 1894146.91% in 2022 and then skyrocketed by 126666.67% in 2024.
- Ani Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$1.93 in 2021, then soared by 84.98% to -$0.29 in 2022, then surged by 114.2% to $0.04 in 2023, then plummeted by 1443.19% to -$0.55 in 2024, then skyrocketed by 304.36% to $1.13 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $1.13 for Q3 2025, versus $0.36 for Q2 2025 and $0.69 for Q1 2025.